Lotus Pharmaceutical Co., Ltd. (1795)
Market Closed
10 Aug, 05:30
TWSE TWSE Primary NT$
193. 50
+5.5
+2.9255%
NT$
80.36B Market Cap
20.79 P/E Ratio
- Div Yield
1.58M Volume
26.65 Eps
NT$ 188
Previous Close Want to track 1795 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | 3.9 | 5.47 |
| | | 3.35 | 4.32 |
| | | - | - |
| | | 5.47 | 5.06 |
| | | 3.8 | - |
| | | 1.43 | - |
| | | 4.66 | 4.75 |
| | | - | - |
| | | - | - |
| | | - | 0.08 |
| | | - | - |
1795 Earnings Reports FAQ
What is the earnings per share (EPS) for 1795?
The current EPS is 26.65.
What is the company's earnings growth rate?
Over the past 12 years, the earnings growth rate has been approximately 46.83%, reflecting the 1795's performance and TWSE market conditions.
When is the next earnings release date?
Lotus Pharmaceutical Co., Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Lotus Pharmaceutical Co., Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 1795 at this time, as Lotus Pharmaceutical Co., Ltd has no recent EPS data to calculate it.
